SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Rhelion Subsidiary Ships PEX010 to USC for Psychedelic Therapy Trial

Rhelion Life Sciences said its wholly owned subsidiary Filament Health shipped PEX010 to the University of Southern California for an expanded mindfulness-assisted psychedelic therapy trial.

RHEL
SquawkNews Desk

Related stories

UL Solutions Reports Quarterly Results for Period Ended September 30 M impact | EQUITY | Nov 03, 2026, 02:33 PM UTC Waters Corp Reports Quarterly Results for Quarter Ended September 30 M impact | EQUITY | Nov 03, 2026, 02:33 PM UTC EBS: trading halted on NYSE — additional information requested (last $6.46) NYSE halted trading in EBS (additional information requested). Last price $6.46. L impact | EQUITY | Nov 03, 2026, 02:33 PM UTC Nasdaq Composite Rises 114.76 Points (0.46%) M impact | EQUITY | Nov 03, 2026, 02:33 PM UTC S&P 500 Rises 14.11 Points (0.19%) M impact | EQUITY | Nov 03, 2026, 02:33 PM UTC DJIA Falls 188.18 Points (0.36%) M impact | EQUITY | Nov 03, 2026, 02:33 PM UTC